Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21330,189,1.13 [0.89-1.44],0.3261704498264702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22508,239,1.05 [0.85-1.30],0.659490927745285
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22231,1714,1.17 [1.08-1.26],0.0001229423722489
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,22515,533,1.10 [0.96-1.27],0.1759557233579552
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21766,4121,1.15 [1.09-1.21],8.235697528441716e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21725,4220,1.20 [1.14-1.26],1.408822765150431e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22235,1399,1.19 [1.09-1.29],0.0001392289581031
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22422,124,0.95 [0.70-1.29],0.7592214492331348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19740,1262,1.18 [1.07-1.29],0.0005064135474828
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19072,1554,1.23 [1.13-1.33],1.1797326617763649e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18561,330,1.31 [1.10-1.56],0.0020401976888408
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14659,2690,1.22 [1.15-1.30],2.7622097779358337e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18507,483,1.43 [1.24-1.64],4.854794303398387e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22489,1653,1.17 [1.08-1.27],0.0001040276960868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Mycoses,22603,621,1.10 [0.96-1.25],0.168981916271269
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21734,1217,1.16 [1.05-1.27],0.0024461091195711
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22532,1391,1.17 [1.07-1.27],0.0005298964487468
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21075,239,1.06 [0.85-1.31],0.6075502758145761
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,22662,66,1.13 [0.75-1.70],0.560096734308319
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22358,1217,1.17 [1.07-1.29],0.0008020664576482
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22374,76,0.94 [0.64-1.40],0.776867627876538
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22598,136,1.50 [1.16-1.93],0.0016901005709361
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22577,115,1.34 [1.00-1.79],0.0499883315871173
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21007,490,1.17 [1.01-1.36],0.0343751366311108
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,20817,300,1.22 [1.02-1.48],0.0331130479444974
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,20968,132,1.06 [0.80-1.42],0.676249306205407
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,22647,46,0.95 [0.57-1.56],0.8249831094659665
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22597,165,1.36 [1.06-1.73],0.0142959043573024
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral warts,22486,54,1.36 [0.89-2.10],0.1570565422858889
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22504,72,1.23 [0.84-1.81],0.2809743737519251
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,22374,259,0.93 [0.75-1.16],0.5260919270152393
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22579,39,0.84 [0.48-1.48],0.548322326638511
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22564,43,0.57 [0.32-1.01],0.0526235357854179
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10805,83,1.07 [0.74-1.55],0.7287780027865154
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22205,1628,1.04 [0.95-1.13],0.3835151271995559
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of meninges,22647,65,1.37 [0.93-2.02],0.1110702994461531
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22571,77,0.94 [0.63-1.39],0.747301581679017
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,22634,115,1.17 [0.87-1.58],0.3112599370109504
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of ovary,11789,73,1.18 [0.80-1.75],0.4031395247042995
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,22622,428,0.98 [0.83-1.16],0.8465450524273974
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Caecum,22628,382,0.93 [0.78-1.12],0.4530126821972825
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22515,82,1.20 [0.84-1.70],0.3110853082935625
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,22620,248,1.04 [0.84-1.28],0.7419382459412953
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Rectum,22581,394,1.14 [0.96-1.34],0.1362422708725746
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22511,658,1.09 [0.96-1.24],0.2045200236187404
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,22606,528,1.04 [0.89-1.20],0.6394066397208884
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Carcinoma in situ of breast,8869,47,0.90 [0.53-1.53],0.6871253218652991
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",8912,64,1.18 [0.77-1.79],0.4502929841433922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16187,69,1.48 [1.01-2.16],0.0418815830226456
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16215,97,1.00 [0.71-1.43],0.9814975779400004
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22605,121,1.15 [0.85-1.56],0.3730792944845625
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma, any site",22606,119,1.17 [0.86-1.59],0.3071236407300126
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Leiomyoma of uterus,11526,160,0.76 [0.56-1.02],0.0711499624631039
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lung cancer and mesothelioma,14342,471,2.06 [1.82-2.34],3.4824149635011504e-29
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lymphoid leukaemia,16189,71,1.41 [0.96-2.06],0.0793359867846922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16339,221,1.08 [0.86-1.36],0.4996936681847354
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16426,308,0.93 [0.77-1.13],0.4885970044731575
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",8987,101,1.25 [0.90-1.74],0.1797740739322892
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16222,104,0.87 [0.62-1.23],0.4288219634436678
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16261,143,1.11 [0.85-1.45],0.4588895261753555
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16237,119,0.91 [0.67-1.24],0.5433979650818801
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8972,86,1.38 [0.99-1.94],0.057937960236213
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16242,124,0.93 [0.68-1.27],0.6516049005454064
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8180,948,0.96 [0.86-1.08],0.5293090737745625
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16250,132,1.03 [0.77-1.39],0.8465076876113615
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16206,88,0.82 [0.57-1.19],0.2991031267059714
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16261,143,1.17 [0.88-1.55],0.2723262602814205
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi,22521,181,1.04 [0.81-1.35],0.7551203821601409
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi of trunk,22635,76,0.74 [0.49-1.13],0.1668671150029894
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanoma in situ,16170,109,1.10 [0.79-1.52],0.5772517037669728
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16236,118,1.08 [0.79-1.48],0.6335071868300706
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16314,196,1.17 [0.92-1.49],0.2045059633239142
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16439,321,1.56 [1.34-1.82],8.075739527057907e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16241,123,1.30 [0.97-1.74],0.0823337347981811
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Other benign neoplasms of skin,22488,158,1.28 [0.99-1.66],0.0589654373975256
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17568,1450,1.03 [0.94-1.13],0.5408029029612191
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17651,1533,1.03 [0.94-1.13],0.5187722841864594
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22368,381,1.08 [0.91-1.28],0.3912167658714891
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20383,161,1.11 [0.86-1.44],0.4284465253038503
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22054,67,1.28 [0.86-1.89],0.2206054631357792
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21912,3423,1.08 [1.02-1.15],0.0055368346177942
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,20975,72,0.97 [0.65-1.44],0.8753367465543845
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22196,64,1.53 [1.06-2.20],0.0219911303048868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22155,1933,1.12 [1.04-1.21],0.003771922018914
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22154,1932,1.11 [1.03-1.20],0.006054073039354
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20333,111,1.26 [0.94-1.71],0.1275599509364993
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22308,1405,1.11 [1.02-1.22],0.0165969028169292
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22243,111,1.33 [0.98-1.79],0.0647921418454373
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22057,70,1.02 [0.68-1.51],0.9304372024694776
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22060,73,1.29 [0.89-1.88],0.1794066306183321
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22483,351,1.24 [1.05-1.48],0.0128965452809644
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22534,38,1.06 [0.60-1.85],0.8488259493681205
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22420,288,1.21 [1.00-1.47],0.0500449756830937
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21033,130,0.89 [0.65-1.21],0.4565996348787163
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15140,408,1.40 [1.21-1.63],1.1968220923679368e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21187,97,1.11 [0.84-1.46],0.4510171222737854
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21198,108,0.94 [0.67-1.31],0.7084283482778779
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14802,70,0.95 [0.63-1.44],0.8242619090808843
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21052,63,0.99 [0.65-1.51],0.9683299371219928
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20286,313,1.26 [1.05-1.51],0.013535036575401
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",21875,950,1.10 [0.99-1.22],0.0861515229284401
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21403,478,0.89 [0.76-1.05],0.1698243832943428
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21143,218,0.95 [0.75-1.21],0.6836645264301626
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22380,1391,1.10 [1.01-1.20],0.0379342583676473
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19051,1347,1.10 [1.01-1.21],0.0309925243229491
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14823,91,1.39 [1.01-1.93],0.0449700943587411
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20409,97,1.21 [0.87-1.69],0.2610706156605965
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15093,361,1.08 [0.90-1.29],0.3980361468513873
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14785,53,1.77 [1.21-2.61],0.0034715798352088
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19244,4512,1.05 [0.99-1.10],0.0831437317629817
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14988,256,1.24 [1.01-1.52],0.0380507643084802
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15427,695,1.19 [1.05-1.35],0.0059504499269717
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22601,359,1.23 [1.04-1.46],0.0155907024800474
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22395,153,1.09 [0.83-1.44],0.525128080007779
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14884,152,1.20 [0.91-1.57],0.1898873019714219
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14809,77,1.17 [0.80-1.72],0.4149270268139863
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22034,1722,1.08 [1.00-1.17],0.0624797185925809
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15111,379,1.53 [1.31-1.78],4.301827037822975e-08
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15150,418,1.44 [1.24-1.68],1.5297220532815362e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15581,849,1.10 [0.98-1.24],0.1039912578691215
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14907,175,0.99 [0.76-1.28],0.922254915477035
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22386,144,1.02 [0.77-1.36],0.8881790259626141
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15618,886,1.13 [1.01-1.26],0.0360436305619729
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15377,645,1.09 [0.96-1.25],0.183877859388021
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20053,80,1.18 [0.81-1.72],0.3849661705943312
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21037,6305,1.07 [1.02-1.11],0.0028216056966786
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20371,59,1.31 [0.87-1.97],0.1987600710571585
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20363,51,1.08 [0.67-1.73],0.7570985387447332
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22480,1866,1.09 [1.01-1.18],0.0313951437540806
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22477,1863,1.09 [1.01-1.18],0.0341747720924063
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20377,65,1.59 [1.12-2.26],0.0088790129361194
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22318,1110,1.15 [1.04-1.27],0.006660190456412
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16937,2205,1.18 [1.10-1.26],5.9429584741233445e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,22646,306,1.17 [0.97-1.40],0.1004180946264925
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21052,127,1.34 [1.02-1.76],0.0388242374685776
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21322,114,0.97 [0.70-1.34],0.8548135291992395
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21365,157,0.86 [0.64-1.14],0.2925505263182517
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14928,196,0.94 [0.73-1.21],0.6263842761221553
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,19925,179,0.94 [0.73-1.22],0.6529129292179594
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2418,95,1.35 [0.97-1.87],0.0742536035458732
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2583,300,1.01 [0.83-1.23],0.9339837712627168
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,19826,80,0.99 [0.69-1.43],0.9658303897829604
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2394,74,1.21 [0.83-1.76],0.3194722299600992
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21834,2088,0.99 [0.92-1.06],0.7158225865219743
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,21551,626,1.08 [0.94-1.24],0.2621161496510552
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20410,437,1.18 [1.00-1.38],0.0444041466145218
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15827,1095,1.17 [1.06-1.29],0.0018385591775234
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22526,301,1.16 [0.96-1.40],0.1310308997474516
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21208,266,1.60 [1.34-1.90],1.0400272236524037e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,19556,1541,1.15 [1.05-1.25],0.0013688221070926
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21311,369,1.43 [1.22-1.66],7.303858201028878e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21027,85,1.68 [1.25-2.27],0.0005826651775972
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21228,286,1.77 [1.51-2.07],1.2075404533850725e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11465,2773,1.19 [1.12-1.27],2.07062453188621e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,AV-block,17206,653,1.11 [0.97-1.27],0.1179571710841209
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22578,569,1.02 [0.88-1.17],0.8137158729516829
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,8953,261,1.30 [1.07-1.57],0.0092696912706057
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16747,194,1.31 [1.05-1.65],0.017854268966762
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16658,105,1.09 [0.78-1.50],0.6168327151641144
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,22657,80,1.39 [0.99-1.96],0.0586724559095887
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Conduction disorders,18062,1509,1.12 [1.03-1.23],0.0084047360291549
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20699,2707,1.17 [1.10-1.25],5.833704821613175e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18173,8702,1.05 [1.01-1.08],0.0191238159410917
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21127,331,1.13 [0.94-1.36],0.1776950853921342
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Endocarditis,16655,102,1.43 [1.06-1.95],0.020570162417786
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22375,1633,1.27 [1.17-1.37],3.3384151452892555e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertension,19386,7755,1.01 [0.97-1.05],0.5107726187910254
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19404,7773,1.01 [0.97-1.05],0.5995917257968189
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22496,89,1.10 [0.78-1.56],0.5950230140327641
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11884,253,1.68 [1.43-1.97],2.3963622428529124e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11836,205,1.42 [1.17-1.74],0.0004756681623681
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,22479,1607,1.30 [1.20-1.40],8.845477230105959e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21389,148,1.15 [0.87-1.51],0.3320871814235729
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20868,2853,1.14 [1.07-1.22],2.183503736572249e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22153,781,1.20 [1.07-1.35],0.0018282528466502
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17065,512,1.23 [1.07-1.42],0.0046317608479986
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,21982,1041,1.25 [1.13-1.38],9.748288782159492e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18914,899,1.28 [1.15-1.43],3.78805962999846e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22535,181,1.28 [1.01-1.61],0.0405063968637744
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",22618,403,1.17 [1.00-1.38],0.0540745609401656
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,20857,61,0.99 [0.64-1.54],0.9679992653364272
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other aneurysm,21043,101,1.37 [1.01-1.85],0.0455427905892808
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17137,584,1.11 [0.96-1.28],0.1474747310336003
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21075,133,1.54 [1.20-1.97],0.0006013114728913
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21264,322,1.50 [1.28-1.77],9.561971623262052e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16773,220,1.54 [1.26-1.89],2.3583220133990444e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,20914,118,1.21 [0.91-1.62],0.1985522565055463
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,20841,45,1.35 [0.86-2.12],0.1882551431690737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,20639,88,0.98 [0.68-1.41],0.9037680861777574
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,20970,174,1.20 [0.94-1.53],0.1473322210506263
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17984,1431,1.26 [1.16-1.38],9.572135221444e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,20933,61,0.91 [0.58-1.41],0.6631496301231701
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21655,713,1.41 [1.26-1.57],2.488461583441307e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21903,514,1.69 [1.50-1.91],6.4966303134762374e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21508,957,1.08 [0.97-1.20],0.1655283217904488
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9103,411,1.24 [1.05-1.45],0.0095026275253146
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21488,578,1.45 [1.28-1.64],2.118736205279069e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21213,417,1.16 [0.99-1.36],0.068411338098064
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,21975,586,1.34 [1.18-1.52],8.80137004368404e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22563,950,1.23 [1.11-1.37],0.0001038456429412
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17057,504,1.12 [0.97-1.31],0.1321489097917387
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21898,509,1.70 [1.51-1.92],3.441331972264637e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,20812,261,1.32 [1.09-1.60],0.0049162086289989
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22137,896,1.20 [1.07-1.33],0.0010776666143122
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22122,935,1.19 [1.07-1.33],0.0009749659687685
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21361,62,1.20 [0.80-1.80],0.3885162392570336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21046,104,1.40 [1.03-1.90],0.0302721398867201
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21691,319,1.08 [0.89-1.30],0.4474698890421659
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21264,323,1.29 [1.08-1.53],0.0046783844750899
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Varicose veins,21303,507,0.99 [0.85-1.15],0.8926315396948524
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,20961,121,1.14 [0.85-1.53],0.3916906538248825
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22386,926,1.23 [1.10-1.36],0.0001655889054409
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22580,319,1.00 [0.84-1.20],0.9891401132586536
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19350,1352,1.13 [1.03-1.23],0.0092526175416461
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,22136,4138,1.09 [1.04-1.15],0.0005037195318435
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22552,376,1.06 [0.90-1.25],0.4560118359276071
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19416,1418,1.11 [1.01-1.21],0.0258711420007379
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18081,83,0.97 [0.67-1.41],0.8845803898907066
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,22158,1154,1.34 [1.25-1.45],1.7323320248838982e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19413,1415,1.28 [1.18-1.39],1.0590823122094259e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Vascular dementia,21767,229,1.01 [0.81-1.27],0.9211293504996568
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Alzheimer disease,22659,584,0.91 [0.79-1.05],0.1942596029563587
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",13879,109,1.15 [0.84-1.58],0.394225703383473
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Bell's palsy,20850,83,0.96 [0.65-1.41],0.824097822688951
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21245,478,1.04 [0.89-1.21],0.6466989927925697
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral cysts,22225,245,1.13 [0.91-1.39],0.2753271103660161
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22586,403,1.28 [1.10-1.50],0.0017438220244525
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,21816,73,1.04 [0.70-1.55],0.8394670903337317
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,22642,67,0.83 [0.54-1.28],0.3898672746386133
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22064,84,1.42 [1.01-1.99],0.0414320113967026
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Epilepsy,21181,298,0.96 [0.78-1.17],0.6746203647922517
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22205,1322,1.10 [1.01-1.21],0.0349686574368062
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,22605,914,0.97 [0.87-1.09],0.6669760157559754
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22012,3401,1.07 [1.01-1.13],0.021879095960132
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,22292,54,0.69 [0.42-1.14],0.15147205965738
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hemiplegia,22510,327,1.33 [1.12-1.57],0.0010628716320955
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hydrocephalus,22056,76,1.15 [0.79-1.68],0.466274735311428
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,22645,69,1.32 [0.90-1.94],0.1604859484908612
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,20833,66,1.05 [0.68-1.61],0.8246877680568574
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,20837,70,1.58 [1.12-2.22],0.0092578003357375
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Memory loss,21519,141,0.79 [0.58-1.08],0.1409193805511245
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Migraine,21155,272,1.24 [1.01-1.51],0.0376847635583065
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22613,249,1.30 [1.06-1.60],0.0122321515061239
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Motor neuron disease,13961,168,1.03 [0.79-1.35],0.8282474616538883
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22531,58,1.08 [0.71-1.65],0.7064872123324948
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",21960,1193,1.06 [0.96-1.17],0.2129140771212383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,21205,4275,1.07 [1.01-1.13],0.0118882780282408
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22066,323,1.12 [0.93-1.34],0.2386255108893524
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21183,416,0.98 [0.82-1.16],0.7806786125502989
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22583,337,1.18 [0.98-1.41],0.075046953692026
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16949,964,1.01 [0.91-1.13],0.8460939528865962
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22064,84,0.89 [0.61-1.29],0.5316863836987882
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22140,160,0.90 [0.69-1.19],0.4681367722879261
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,21924,233,1.14 [0.92-1.42],0.2441674642762292
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,20860,93,1.06 [0.75-1.51],0.7446285028739422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other headache syndromes,20933,50,1.22 [0.77-1.95],0.3957441281365739
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other neurological diseases,22551,571,1.05 [0.91-1.21],0.5219269904986028
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other sleep disorders,21391,508,1.11 [0.96-1.29],0.1610385162521771
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Parkinson's disease,22626,677,0.99 [0.87-1.14],0.9338438236203846
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22025,45,0.68 [0.39-1.20],0.1835212282931714
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,22659,109,1.05 [0.76-1.46],0.7658683352919988
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Sleep apnoea,22427,431,1.15 [0.98-1.34],0.0870029857463402
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22303,57,1.33 [0.87-2.04],0.1878074433548524
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,22648,194,0.99 [0.77-1.27],0.9102368277537872
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,20833,66,0.89 [0.58-1.38],0.60641551820682
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,22659,590,0.91 [0.78-1.05],0.1794741937654859
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),21708,223,1.04 [0.83-1.30],0.7574210477809242
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22029,151,1.13 [0.87-1.48],0.3678965256249211
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22214,555,1.14 [0.99-1.32],0.0712019385489395
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22407,262,0.82 [0.66-1.02],0.0725564924277265
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21454,66,1.28 [0.86-1.91],0.227901206653203
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21427,39,1.26 [0.75-2.12],0.3825118462064294
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",22538,65,1.13 [0.75-1.71],0.5517781270654238
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22348,221,1.14 [0.91-1.43],0.2532549665157886
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2398,75,1.25 [0.86-1.82],0.2359647156520558
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2961,110,1.44 [1.07-1.94],0.0154940581061094
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,21980,102,1.31 [0.95-1.79],0.0981799097302397
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22367,1408,0.92 [0.84-1.01],0.0783051031837546
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22254,866,1.12 [1.00-1.25],0.0573725356021357
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21690,302,1.12 [0.93-1.36],0.2422104856944782
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22586,927,1.00 [0.90-1.12],0.9531735650649376
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,22652,82,0.90 [0.61-1.33],0.6024032004668542
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22515,856,1.00 [0.89-1.13],0.9872715274277294
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",22619,492,1.03 [0.88-1.21],0.6951038799196589
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,22541,221,0.99 [0.78-1.25],0.913318423607742
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21484,96,1.13 [0.80-1.58],0.4972830599912821
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21487,99,1.01 [0.72-1.41],0.9632559348349126
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21465,77,0.98 [0.66-1.46],0.911390290772035
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22529,989,1.03 [0.92-1.15],0.6328614669459918
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,21798,258,1.08 [0.87-1.34],0.4771636104902808
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,21729,70,0.64 [0.40-1.00],0.0512582447254189
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22247,120,1.01 [0.74-1.39],0.9367632940862108
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22511,384,1.03 [0.86-1.23],0.7665358458706245
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,21873,214,0.80 [0.63-1.03],0.0848282028674962
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22459,139,0.94 [0.70-1.27],0.6907075543389006
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22202,662,1.05 [0.92-1.20],0.4696160602457061
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22038,160,1.06 [0.81-1.38],0.6906003084169824
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20242,3158,0.98 [0.92-1.04],0.5712806105449337
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22467,340,0.93 [0.77-1.13],0.4860322437822406
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,22646,184,0.98 [0.75-1.26],0.8485920322189046
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21913,525,1.11 [0.96-1.28],0.1664919637935092
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22216,89,1.15 [0.81-1.64],0.4369476482922022
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,22643,73,0.92 [0.61-1.37],0.6682926964676666
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21512,124,1.16 [0.86-1.57],0.3225986232227708
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21559,171,1.30 [1.02-1.66],0.0320148677107313
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21122,163,0.89 [0.67-1.18],0.4196703640974742
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,21721,62,1.01 [0.65-1.56],0.9809689621584414
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21028,69,0.87 [0.56-1.33],0.514337471941654
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,21651,111,1.13 [0.82-1.56],0.4394834391334502
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",21826,286,0.86 [0.70-1.07],0.1734505787643242
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21544,156,1.10 [0.84-1.43],0.5032997833048874
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21051,92,0.77 [0.52-1.13],0.1748690230785158
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21087,128,1.02 [0.75-1.39],0.9043624313332465
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19772,2688,1.07 [1.00-1.14],0.0591279232452089
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21480,92,1.25 [0.89-1.75],0.2036458836198833
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22371,493,1.14 [0.98-1.32],0.0845733876712455
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,21953,75,1.31 [0.92-1.87],0.1303214506880188
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22080,202,1.06 [0.83-1.34],0.6409627112773155
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22442,109,0.84 [0.59-1.19],0.3231616114201699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,22611,137,1.04 [0.78-1.39],0.7767213735244353
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22524,111,0.97 [0.70-1.35],0.8613312599193983
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22394,61,1.50 [1.01-2.20],0.0421769781749589
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22398,65,1.19 [0.79-1.80],0.4057261546357883
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,22551,1216,1.02 [0.93-1.13],0.6769140750353176
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22258,923,1.07 [0.95-1.19],0.2581347740060071
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21484,149,0.67 [0.50-0.92],0.0115158084314126
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21421,86,0.87 [0.59-1.28],0.4796387513408245
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,22473,63,1.10 [0.72-1.68],0.6651946121320952
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22587,177,1.16 [0.91-1.49],0.2395474018990153
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22471,61,1.41 [0.95-2.08],0.089341012015953
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza,20036,154,1.55 [1.23-1.95],0.0002183928249359
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20033,151,1.51 [1.19-1.92],0.0006361397668018
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13973,102,0.84 [0.58-1.22],0.3632359555105983
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,22554,232,0.68 [0.53-0.87],0.0019763057712654
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15159,1671,1.16 [1.07-1.26],0.0004860071874776
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15520,1649,1.16 [1.07-1.26],0.0005675432987644
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22155,174,1.28 [1.01-1.61],0.0426285110281972
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",19985,103,1.36 [1.01-1.84],0.0410837084666242
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bronchiectasis,19014,506,1.59 [1.40-1.82],1.938184096095742e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18578,70,1.56 [1.11-2.20],0.0105642803333325
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21560,3052,1.27 [1.20-1.34],2.6924634320827196e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21450,70,0.79 [0.51-1.22],0.2881154030591587
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,21513,133,1.05 [0.79-1.42],0.7234405911838486
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22375,1595,1.43 [1.33-1.54],2.6545994782300907e-22
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,21462,82,0.90 [0.61-1.32],0.5843078762425038
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20553,5981,1.19 [1.14-1.24],4.291493329519564e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21714,334,0.95 [0.79-1.15],0.5929722267566511
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,20887,107,1.83 [1.42-2.36],2.51351480860265e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Emphysema,18929,421,1.94 [1.71-2.20],2.1164786902870743e-24
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21401,438,2.47 [2.22-2.74],3.293320495526973e-64
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22407,2525,1.34 [1.26-1.43],1.209240589740291e-20
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21442,479,2.40 [2.17-2.66],2.2216131827313257e-63
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Later onset COPD,22152,1488,1.41 [1.31-1.52],4.1233645481786523e-19
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,22643,482,1.17 [1.01-1.35],0.039321590686317
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,21474,94,0.94 [0.66-1.34],0.7329755865682048
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22378,1262,1.35 [1.24-1.48],7.838619821666586e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22376,2627,1.24 [1.17-1.32],6.789124694739096e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22118,738,0.86 [0.75-0.98],0.0214565051817776
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other pleural conditions,19817,68,1.61 [1.13-2.30],0.0089486188589949
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22542,573,2.16 [1.96-2.39],3.2551811950217114e-53
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22535,1680,1.26 [1.16-1.36],5.3749417582019e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,21087,1338,1.23 [1.12-1.34],5.656473784679296e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural plaque,19995,246,1.44 [1.19-1.75],0.0001870177544955
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22124,2242,1.34 [1.26-1.43],7.790270421193038e-19
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22538,377,1.04 [0.87-1.23],0.6894027811430669
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumothorax,19912,163,1.37 [1.08-1.74],0.0106785596808666
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pollen allergy,22648,197,0.69 [0.52-0.90],0.0062319233773407
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,22060,91,1.38 [1.00-1.91],0.0469639434844069
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13940,69,1.64 [1.13-2.40],0.0099635046655284
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22356,1240,1.36 [1.25-1.48],5.1917428034882334e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21614,234,0.67 [0.53-0.86],0.0017911547145206
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Viral pneumonia,20175,293,1.37 [1.14-1.64],0.0007441998093885
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22164,236,1.37 [1.12-1.68],0.0021045526022372
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7224,115,1.04 [0.76-1.43],0.8119278624906452
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14349,61,1.12 [0.74-1.71],0.5871306378862645
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute appendicitis,22546,126,1.14 [0.85-1.53],0.3703494750652019
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute gastritis,15765,106,1.25 [0.91-1.72],0.1727926088638295
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,20665,188,1.23 [0.97-1.56],0.082305264468803
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute peritonitis,22179,108,1.06 [0.77-1.45],0.7413424774269946
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,21710,62,1.11 [0.75-1.64],0.6147204829114279
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,16153,494,1.11 [0.95-1.29],0.1987583007623463
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20619,142,1.25 [0.96-1.64],0.1024285512684172
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22249,142,1.25 [0.95-1.63],0.1068998738415254
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholecystitis,20689,212,1.08 [0.86-1.36],0.4941044381332546
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholelithiasis,21495,1018,1.08 [0.97-1.20],0.1369450686835579
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic gastritis,15999,340,1.03 [0.85-1.24],0.7829188344708873
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20530,53,0.87 [0.54-1.41],0.5690823656818993
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22526,119,1.25 [0.94-1.68],0.1250311134636041
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,20954,123,1.35 [1.02-1.80],0.0376200835655066
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Collagenous colitis,20952,102,1.30 [0.95-1.77],0.1068445457074576
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22543,154,0.74 [0.56-0.99],0.0447088959462197
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Constipation,22382,2089,1.05 [0.98-1.13],0.1938144477489655
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn disease,20936,86,1.40 [1.00-1.95],0.0474912190789632
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22316,65,1.33 [0.90-1.96],0.1501621471409958
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,20929,79,1.38 [0.98-1.96],0.0664479732052159
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Dental caries,22067,187,1.02 [0.80-1.31],0.872090037413719
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19592,2510,1.12 [1.04-1.20],0.0012541072878498
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of appendix,22576,156,1.17 [0.90-1.52],0.2505778738344149
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,22540,892,1.09 [0.97-1.22],0.1368572508229763
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20149,4490,1.07 [1.02-1.13],0.0088572645215891
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22340,460,1.03 [0.88-1.20],0.7353154736360812
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22570,499,1.08 [0.93-1.26],0.3128666637561375
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,21972,92,1.00 [0.70-1.42],0.9806056139089964
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,21846,59,0.92 [0.59-1.44],0.7224851223287112
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22334,1503,1.13 [1.04-1.23],0.0036696350875449
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of tongue,21862,92,1.12 [0.79-1.59],0.5099138819285474
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21952,1475,1.07 [0.98-1.17],0.1431306708145507
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17984,3696,1.04 [0.98-1.10],0.2012526877973457
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15903,244,1.07 [0.86-1.33],0.5464402952419987
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22565,198,0.94 [0.74-1.21],0.6487749077302118
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22623,26,0.70 [0.33-1.48],0.3515804304584841
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,21788,140,1.27 [0.97-1.65],0.0815204518606146
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14395,107,0.83 [0.59-1.17],0.2923031507959036
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16211,552,1.08 [0.94-1.25],0.2834664315101133
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastric ulcer,16081,422,1.21 [1.03-1.42],0.0170407525498623
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18261,2602,1.05 [0.98-1.12],0.1981598519879441
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16302,643,1.15 [1.01-1.31],0.0372511501246223
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16356,8043,1.02 [0.98-1.06],0.3836797952844788
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,GI-bleeding,22084,1253,1.16 [1.06-1.27],0.0016597647931031
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,21925,45,0.65 [0.37-1.15],0.1426815475926075
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15264,1165,0.99 [0.89-1.10],0.8792332139273815
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",21714,66,1.13 [0.76-1.67],0.5545921103642483
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Hernia,20649,3567,1.06 [1.00-1.12],0.054158430484089
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impacted teeth,22627,24,0.67 [0.31-1.48],0.3246833237113441
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impaction of intestines,14365,77,0.96 [0.64-1.42],0.8239068943942737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,18156,1074,0.97 [0.87-1.08],0.5741674832282555
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17203,121,1.00 [0.73-1.38],0.9876618856212336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14403,115,0.71 [0.51-1.01],0.0556710608688398
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,20970,139,1.37 [1.04-1.79],0.0229630791075059
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14789,501,1.16 [1.00-1.35],0.0540700816034169
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,22626,329,1.01 [0.84-1.22],0.9228289680829737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21623,773,1.18 [1.05-1.33],0.0046550916463094
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21919,1069,1.14 [1.04-1.27],0.0083290097013631
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15871,212,1.03 [0.81-1.31],0.7948276060513306
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophagitis,16341,682,1.11 [0.98-1.27],0.1035287680005369
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22605,133,0.89 [0.66-1.20],0.453473049313276
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17169,87,1.22 [0.86-1.75],0.2697066050620196
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15645,1357,1.01 [0.92-1.11],0.7854557371194881
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20831,354,1.06 [0.88-1.26],0.5488291521868037
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,20619,142,0.88 [0.65-1.18],0.3771001147009263
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16178,1890,1.11 [1.02-1.19],0.009732460994893
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,20385,6097,1.02 [0.98-1.07],0.2723597994704651
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21826,208,0.89 [0.70-1.13],0.3475175859706898
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,22384,736,1.08 [0.96-1.23],0.193897882666132
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16407,748,1.14 [1.01-1.29],0.0396688135462178
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,20688,211,1.13 [0.90-1.42],0.2900634409293193
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22494,423,1.09 [0.93-1.29],0.2834583928271343
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16732,1073,1.11 [1.00-1.23],0.0491214026499803
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22100,1269,1.15 [1.05-1.26],0.0026045952005998
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22051,171,1.23 [0.96-1.57],0.1003096620797635
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16423,2135,1.05 [0.97-1.13],0.2275928978215879
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17788,2129,1.12 [1.04-1.21],0.00165885866402
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,21758,110,0.74 [0.52-1.04],0.0829343468185708
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21796,946,1.15 [1.04-1.28],0.0081441714675175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14725,437,1.18 [1.01-1.38],0.0396202627232342
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22619,29,0.74 [0.37-1.51],0.4110672119058597
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14896,608,1.08 [0.94-1.24],0.2719174307999519
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",20982,151,0.90 [0.68-1.19],0.4637258963224544
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,22647,52,0.86 [0.53-1.41],0.5583197037487451
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,21872,99,0.98 [0.69-1.39],0.9179185520443336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Toxic colitis,20926,76,1.28 [0.89-1.86],0.1854048591490471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15991,332,1.05 [0.87-1.27],0.6046894143243784
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21013,163,0.96 [0.73-1.26],0.7631468825299963
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",20979,129,0.95 [0.70-1.29],0.7265879374903387
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,17329,247,1.06 [0.85-1.31],0.6227140062673742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14529,241,1.23 [1.00-1.52],0.0449218208987917
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ventral hernia,17359,277,1.10 [0.90-1.34],0.3731488223684638
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Volvulus,14383,95,0.90 [0.62-1.29],0.5586963404167844
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,22555,417,0.97 [0.82-1.15],0.7296881209493183
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22306,63,1.19 [0.79-1.81],0.4101134223281077
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20147,162,1.02 [0.78-1.35],0.867330954110448
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22035,804,1.15 [1.03-1.29],0.0166996278697045
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21372,141,1.08 [0.81-1.43],0.5984813376442814
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20603,618,1.15 [1.01-1.31],0.039249049976267
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22322,312,1.03 [0.85-1.25],0.7679261430384403
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22559,549,1.10 [0.95-1.26],0.2015559414746114
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22057,47,1.08 [0.66-1.79],0.7547377206898687
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21083,3657,1.07 [1.01-1.13],0.0242120469676269
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22231,427,1.05 [0.89-1.24],0.5494582539151134
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22104,300,1.05 [0.86-1.27],0.654366741161964
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22277,1046,1.13 [1.02-1.25],0.0165176933044876
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",22640,59,0.77 [0.48-1.26],0.3004108960722229
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20041,56,1.22 [0.80-1.86],0.3509343445317986
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21863,59,1.09 [0.71-1.68],0.6885600596646071
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22309,299,1.04 [0.86-1.27],0.6765822022890979
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20579,594,1.05 [0.91-1.21],0.4911365438375442
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20075,90,1.06 [0.74-1.51],0.7468407804557069
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,22571,96,1.21 [0.87-1.68],0.2505674475362136
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21463,232,1.21 [0.98-1.50],0.0756752463926914
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22461,218,1.16 [0.93-1.44],0.2014302397668615
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22103,93,1.54 [1.14-2.08],0.0045740072700052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20062,77,0.77 [0.51-1.17],0.2194979036561756
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22054,2069,1.06 [0.99-1.14],0.1104307442734509
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20619,634,1.06 [0.92-1.21],0.4195284177338646
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20078,93,1.03 [0.73-1.47],0.8640157007106449
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22572,329,1.10 [0.91-1.32],0.3266101870480383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22082,72,1.19 [0.81-1.74],0.3864205885262499
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22512,269,1.17 [0.95-1.42],0.1349776821124832
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22587,449,0.99 [0.84-1.17],0.9135087867567546
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20105,120,0.97 [0.71-1.34],0.868901472795834
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20318,333,0.92 [0.76-1.11],0.3796678760096537
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22575,437,0.98 [0.83-1.16],0.832811854071254
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20313,328,1.21 [1.02-1.44],0.0332886931878547
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,22630,155,1.02 [0.78-1.34],0.8724760561196089
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,18860,77,0.82 [0.54-1.24],0.3476465698754052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19975,6310,1.02 [0.97-1.06],0.4883016561535657
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18586,4921,1.02 [0.97-1.07],0.4052840122074449
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,18832,49,0.76 [0.45-1.29],0.3122915213915624
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18789,144,1.27 [0.98-1.66],0.0695024930996118
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18834,189,1.05 [0.82-1.35],0.6802621343019682
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22400,65,1.09 [0.72-1.66],0.6789272987177862
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",18792,147,1.13 [0.87-1.48],0.3622254732855066
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15127,1462,1.13 [1.03-1.24],0.0074775904022516
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22452,244,1.05 [0.84-1.30],0.6818289590629372
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19222,577,1.05 [0.91-1.21],0.5170801358096463
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18337,7873,1.02 [0.98-1.06],0.3956068072954388
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20160,116,1.08 [0.79-1.47],0.6452864697985119
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,18965,182,1.15 [0.91-1.47],0.2474700611041165
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19280,497,0.98 [0.84-1.14],0.7732275026672348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21737,3092,1.07 [1.01-1.14],0.0240361276762874
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19089,306,1.14 [0.94-1.38],0.1770742105491988
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,18929,146,0.86 [0.64-1.16],0.3170151901601564
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18894,111,0.83 [0.59-1.17],0.2884428765954968
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,21930,95,0.94 [0.66-1.35],0.7532287356081866
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15627,1962,0.98 [0.90-1.06],0.6039118789386744
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14438,773,1.11 [0.98-1.25],0.0937179596135281
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22567,767,1.10 [0.98-1.24],0.1106946086771728
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13740,75,0.93 [0.61-1.40],0.7213603613606163
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),13966,301,0.81 [0.66-1.01],0.0562724018513308
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19046,263,0.82 [0.66-1.03],0.0845145427554347
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14137,472,0.99 [0.84-1.17],0.9368993664890992
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18725,80,0.90 [0.61-1.33],0.5928753167755167
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19319,674,1.14 [1.00-1.29],0.0437245177825513
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18956,311,1.12 [0.92-1.35],0.2561563082560864
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14107,442,0.96 [0.81-1.13],0.5983139858786699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,18854,71,0.88 [0.58-1.34],0.553577830581811
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",18843,60,0.96 [0.61-1.51],0.8662001481339052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20126,82,0.86 [0.58-1.27],0.4386425961521901
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22233,2189,1.08 [1.00-1.16],0.0478802442512012
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21583,1539,1.06 [0.97-1.15],0.2224106231988322
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22487,533,1.24 [1.08-1.43],0.0022157500518104
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16730,3065,1.06 [0.99-1.13],0.0753583480780222
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13707,42,0.95 [0.55-1.66],0.8676746785220646
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,18885,102,1.18 [0.85-1.65],0.3135049237065137
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13734,69,1.35 [0.92-1.99],0.1305843686089899
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13800,135,0.76 [0.55-1.05],0.0969465171365479
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20285,241,1.17 [0.95-1.45],0.1402813697355645
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20547,503,1.16 [1.00-1.35],0.046720694281648
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,22635,111,0.96 [0.69-1.35],0.8309706214975845
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20597,1952,1.09 [1.01-1.17],0.0343044335303384
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18859,76,1.02 [0.69-1.53],0.9055318636794776
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13816,151,0.86 [0.64-1.16],0.324062710762604
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19423,778,1.06 [0.94-1.20],0.321691968188372
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15806,2141,1.01 [0.94-1.09],0.7593447952160688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,21955,120,1.24 [0.92-1.66],0.1516905404761481
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,22647,60,1.22 [0.80-1.86],0.3616265759736201
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18860,77,0.89 [0.60-1.32],0.5645185486087141
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20115,1332,1.01 [0.92-1.11],0.8360105358278793
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,18890,107,1.03 [0.74-1.44],0.8574220844574177
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15705,2040,1.08 [1.00-1.17],0.0418419676714618
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20163,119,1.01 [0.74-1.39],0.950768105822002
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,18819,36,1.31 [0.77-2.24],0.3249124200907945
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18832,187,1.30 [1.04-1.63],0.0227172714180175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19460,677,1.04 [0.91-1.18],0.5706510779737144
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22313,478,1.16 [1.00-1.36],0.05486788548419
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19299,654,1.19 [1.05-1.35],0.0069768297737632
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22502,528,1.27 [1.10-1.46],0.0007596787323284
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,22632,69,1.44 [1.00-2.08],0.051725392820136
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,18949,166,0.99 [0.76-1.30],0.9604475680662212
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17623,871,1.08 [0.96-1.21],0.1875422527497291
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19417,634,1.04 [0.91-1.19],0.5244334609796175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19059,276,1.15 [0.95-1.41],0.1594054964881726
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13734,69,1.07 [0.71-1.62],0.7299020531223203
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16731,3066,1.09 [1.03-1.16],0.0044268676145636
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14490,825,1.08 [0.96-1.21],0.2253896697657988
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22205,370,1.13 [0.95-1.35],0.1690050073790668
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",22604,80,0.96 [0.65-1.43],0.8507357042992266
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20059,70,0.85 [0.56-1.30],0.4478894680797817
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13726,61,1.24 [0.82-1.90],0.3105925439103543
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18754,109,1.44 [1.08-1.91],0.0130685803513457
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14205,540,1.25 [1.09-1.44],0.0016741483285302
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19112,329,1.05 [0.87-1.27],0.6283803619522006
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18925,280,0.98 [0.80-1.20],0.8423048742343684
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,18909,264,1.08 [0.88-1.34],0.4430150429501496
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15927,67,0.91 [0.59-1.39],0.6503828130871383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",22637,74,1.43 [1.00-2.03],0.0498274386661851
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19325,542,0.98 [0.85-1.14],0.8168047606446118
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],21924,89,1.35 [0.97-1.90],0.0790089555885113
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21384,2601,1.03 [0.97-1.10],0.3494248423664076
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",18932,149,1.13 [0.86-1.49],0.3712117137323876
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19352,707,1.07 [0.94-1.21],0.3035475042671133
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21326,263,1.21 [0.99-1.48],0.0626570486477148
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18895,250,1.11 [0.89-1.37],0.3588272214922033
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20618,1973,1.11 [1.03-1.19],0.0072338200754622
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19936,1291,1.19 [1.09-1.30],0.0001635239419191
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],18842,59,1.46 [0.98-2.19],0.0619365086577482
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,21949,114,1.27 [0.94-1.72],0.1155294348642841
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,18943,160,1.11 [0.85-1.45],0.4469618617094816
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,18875,92,1.03 [0.72-1.47],0.8872626100932111
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),13741,76,1.09 [0.74-1.60],0.6737506682263884
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21186,2212,1.24 [1.16-1.32],9.348080063074844e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9058,24,0.65 [0.30-1.43],0.2840828653013813
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11499,34,0.61 [0.32-1.20],0.1525958097592422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22334,295,1.06 [0.87-1.29],0.57360565684876
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22138,99,1.32 [0.96-1.82],0.0888596381739927
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21251,2277,1.21 [1.13-1.30],2.592004282224365e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22430,130,1.28 [0.97-1.68],0.0829036371051169
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22353,398,1.07 [0.91-1.27],0.4077083212512719
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cystitis,18893,297,1.00 [0.82-1.22],0.9825444547602196
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dialysis,19068,94,1.51 [1.11-2.05],0.0087769921902732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9987,2089,1.01 [0.94-1.09],0.753285835653292
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11599,134,1.04 [0.77-1.39],0.8079831605765729
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9071,37,0.70 [0.37-1.32],0.2706061411479915
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9609,575,0.88 [0.76-1.03],0.1108616373710467
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18656,6150,1.06 [1.01-1.10],0.0132559843912814
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22396,96,1.28 [0.93-1.76],0.1330426073534893
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8010,112,1.30 [0.96-1.76],0.0874717012300362
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19039,340,0.85 [0.70-1.04],0.1086797583826918
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9676,1778,0.99 [0.91-1.08],0.8468121792798122
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11665,156,1.06 [0.81-1.40],0.6576130579624462
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8023,125,0.90 [0.66-1.23],0.4947082280023077
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18682,86,0.90 [0.61-1.31],0.5663766851599497
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10051,1017,0.94 [0.85-1.06],0.3206745690574357
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7959,61,1.38 [0.93-2.05],0.1100810126503816
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9072,38,1.24 [0.75-2.05],0.4071452267818423
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",22645,86,0.80 [0.54-1.19],0.2755123017626645
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",22647,80,1.30 [0.92-1.85],0.1362306608629729
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21488,2892,1.06 [1.00-1.13],0.0500329902397282
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19510,914,1.07 [0.95-1.19],0.2568600777805511
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11516,51,0.93 [0.56-1.53],0.7667113012971261
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22574,619,1.16 [1.02-1.32],0.0270249041838033
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8048,150,1.17 [0.89-1.52],0.2595959446980935
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8057,159,0.99 [0.76-1.30],0.9570813732357808
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8043,145,0.74 [0.55-1.00],0.0526321826534292
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,22618,84,0.88 [0.60-1.30],0.5226823000980476
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20899,2303,1.07 [0.99-1.14],0.0761533591032008
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11589,80,1.04 [0.71-1.53],0.8313132424264134
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9103,69,1.19 [0.79-1.77],0.4058778331303571
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9174,140,0.94 [0.69-1.26],0.6629977593690779
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9083,49,0.93 [0.56-1.55],0.7802335477772309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9133,99,1.11 [0.79-1.56],0.5495871593003282
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19101,402,0.83 [0.69-0.99],0.040805701693713
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22154,199,1.28 [1.02-1.60],0.0297447537194113
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9157,123,1.14 [0.85-1.55],0.3844478682816216
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9059,25,0.97 [0.48-1.94],0.9233130222300746
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9242,208,1.09 [0.86-1.38],0.4697963918503673
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9124,90,0.70 [0.47-1.04],0.0795995505608873
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9236,202,1.12 [0.88-1.41],0.362998158651304
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22348,48,1.21 [0.76-1.93],0.4241008002093503
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8051,153,0.89 [0.67-1.17],0.4001402660264347
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22371,3672,1.17 [1.11-1.24],6.0132267652610515e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18790,91,1.04 [0.72-1.50],0.8302109421492911
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19151,177,1.39 [1.11-1.74],0.004227138170352
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22074,35,0.72 [0.39-1.34],0.3020057236613621
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18857,261,1.10 [0.90-1.36],0.3531718957411904
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22415,376,1.08 [0.91-1.29],0.3652035808215987
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9069,35,1.27 [0.75-2.15],0.3806220346218444
